Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Thérapie par cellules CAR-T dans les maladies auto-immunes en tant qu'indication principale ou concomitante : une étude en deux étapes au nom du groupe de travail ADWP et du groupe de travail CTIWP de l'EBMT

Maladies auto-immunes

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Raffaella Greco

CAR-T Cell Therapy in Autoimmune Diseases as Concomitant or Main Indication: a 2-step Joint Study on behalf of EBMT ADWP and CTIWP

Closed Survey/Study

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Raffaella Greco

Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Autoimmune Diseases Working Party (ADWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Secondary autoimmune and inflammatory diseases (sec.AIID) post allogeneic HSCT

Retrospective Studies

Transplant Complications Working Party (TCWP)

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Arsene Mekinian

Incidence and outcome of CMV and EBV reactivations after autologous HSCT for autoimmune diseases: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Tobias Alexander

Comparison of Cyclophosphamide/ATG vs BEAM/ATG conditioning regimens in autologous HSCT for Multiple Sclerosis

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Riccardo Saccardi

Observational Study in Multiple Sclerosis patients treated with autologous hematopoietic stem cell Transplantation (OMST)

Non-interventional Prospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Riccardo Saccardi

Outcomes of HSCT for autoimmune cytopenias (AIC): a Retrospective Registry Study from the Autoimmune Diseases Working Party (ADWP) and the Paediatric Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Autoimmune Diseases Working Party (ADWP)

Transplant Complications Working Party (TCWP)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Kirill Kirgizov

Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2)

Non-interventional Prospective Studies

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Pr Dominique Farge

ASTIMS: High dose immunoablation and autologous haematopoietic stem cell transplantation versus mitoxantrone therapy in severe multiple sclerosis

Clinical Trials Phase I-III

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Paediatric Multiple Sclerosis

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

J Burman, K Kirgizov